Picture of Biotage AB logo

BIOT Biotage AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Biotage AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line212223269348303
Depreciation
Non-Cash Items2.13-11.74-1714
Other Non-Cash Items
Changes in Working Capital-76.7-5.925-92-182
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities212279353341284
Capital Expenditures-45.5-60.9-56-70-91
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-40.2-0.379-285-14126
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-85.7-61.3-341-8435
Financing Cash Flow Items-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-119-22.7-82-133-142
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8.85185-61131153